6533b7cffe1ef96bd1258276

RESEARCH PRODUCT

Metastatic pattern of breast cancer according to immunohistochemical defined subtypes in the transitional phase of adjuvant trastuzumab treatment.

Sherko KümmelAndreas Du BoisWolfgang WeikelAlexander QueckAlexander TrautFlorian HeitzF Lorenz-salehiJohannes HoltschmidtAnnette Fisseler-eckhoffOndra Du BoisGeorg ArnoldPhilipp Harter

subject

OncologyGynecologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseTransitional phaseBreast cancerOncologyTrastuzumabInternal medicineMedicineImmunohistochemistryskin and connective tissue diseasesbusinessneoplasmsAdjuvantmedicine.drugEarly breast cancer

description

e11581 Background: Prognosis of early breast cancer (BC) differs significantly upon subtypes (ST). Treatment with adjuvant trastuzumab improves outcome of HER2 overexpressing BC, however, less in k...

https://doi.org/10.1200/jco.2014.32.15_suppl.e11581